Cellular Logistics
Cellular Logistics is a pioneering biotech company advancing regenerative therapies to heal the damaged heart. Its lead innovation, CFX™, is a first-of-its-kind therapeutic biomaterial developed with induced pluripotent stem cell technology, designed to prevent heart failure progression, repair damaged tissue, stimulate new blood vessel formation, and reduce scarring after cardiac injury.
Strategically based in Madison, Wisconsin—an established hub for scientific discovery—Cellular Logistics is driving forward solutions that address one of the world’s most urgent health challenges: cardiovascular disease. CFX™ offers versatile application options, functioning as either a standalone treatment or a complementary therapy to improve the effectiveness of other interventions, with the potential to revolutionize cardiac regeneration. By combining breakthrough science, robust intellectual property, and a mission to transform patient outcomes, Cellular Logistics is positioned to make significant contributions in the fight against heart failure worldwide.
